These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 18261379)

  • 1. [Anti-TNF alpha agents in vasculitis].
    Solans Laqué R; Bosch Gil JA
    Med Clin (Barc); 2008 Feb; 130(3):93-4. PubMed ID: 18261379
    [No Abstract]   [Full Text] [Related]  

  • 2. [Are anti-TNFAb indicated in systemic necrotizing vasculitides?].
    Guillevin L
    Rev Med Interne; 2005 Oct; 26(10):769-70. PubMed ID: 16039017
    [No Abstract]   [Full Text] [Related]  

  • 3. [TNF-alpha inhibitors].
    Fain O
    Rev Prat; 2003 Nov; 53(18):1989-90. PubMed ID: 15008210
    [No Abstract]   [Full Text] [Related]  

  • 4. Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation.
    Booth AD; Jayne DR; Kharbanda RK; McEniery CM; Mackenzie IS; Brown J; Wilkinson IB
    Circulation; 2004 Apr; 109(14):1718-23. PubMed ID: 15037536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologics in vasculitides: Where do we stand, where do we go from now?
    Pazzola G; Muratore F; Pipitone N; Salvarani C
    Presse Med; 2015 Jun; 44(6 Pt 2):e231-9. PubMed ID: 26024760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis.
    Hoffman GS; Merkel PA; Brasington RD; Lenschow DJ; Liang P
    Arthritis Rheum; 2004 Jul; 50(7):2296-304. PubMed ID: 15248230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti TNF-α in refractory Takayasu's arteritis: cases series and review of the literature.
    Comarmond C; Plaisier E; Dahan K; Mirault T; Emmerich J; Amoura Z; Cacoub P; Saadoun D
    Autoimmun Rev; 2012 Jul; 11(9):678-84. PubMed ID: 22155781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up.
    Molloy ES; Langford CA; Clark TM; Gota CE; Hoffman GS
    Ann Rheum Dis; 2008 Nov; 67(11):1567-9. PubMed ID: 18677012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological therapies: new treatment options for ANCA-associated vasculitis?
    Aries PM; Lamprecht P; Gross WL
    Expert Opin Biol Ther; 2007 Apr; 7(4):521-33. PubMed ID: 17373903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biotherapies for the treatment of asthma: are they the treatment of the future?].
    Tonnel AB; Denis G; Lelong J
    Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S44-10S48. PubMed ID: 17127963
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of ANCA-associated vascularitides].
    Guillevin L; Pagnoux C
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Churg-Strauss syndrome--recent developments in diagnosis and treatment].
    Hellmich B; Metzler C; Gross WL
    Dtsch Med Wochenschr; 2006 Oct; 131(41):2270-4. PubMed ID: 17036268
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders.
    Aeberli D; Oertle S; Mauron H; Reichenbach S; Jordi B; Villiger PM
    Swiss Med Wkly; 2002 Jul; 132(29-30):414-22. PubMed ID: 12428187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trials in vasculitis associated with anti-neutrophil cytoplasmic antibodies.
    Goek ON; Stone JH
    Curr Opin Rheumatol; 2005 May; 17(3):257-64. PubMed ID: 15838233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biologic therapy with anti-TNFα in spondyloarthritides and other autoimmune diseases].
    Lapadula G
    Reumatismo; 2005; 57(4 Suppl):22-9. PubMed ID: 16385352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Common variable immunodeficiency and sarcoidosis: what is the link?].
    Agostini C; Semenzato G
    Ann Ital Med Int; 2002; 17(2):77-80. PubMed ID: 12150049
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biologicals in the treatment of rheumatic diseases].
    Scherer HU; Burmester GR
    Dtsch Med Wochenschr; 2006 Oct; 131(41):2279-85. PubMed ID: 17036270
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of primary systemic vasculitis with TNF alpha-antagonists].
    Gause A; Arbach O; Lamprecht P
    Z Rheumatol; 2003 Jun; 62(3):228-34. PubMed ID: 12827398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and future use of anti-TNF agents in the treatment of autoimmune, inflammatory disorders.
    Calamia KT
    Adv Exp Med Biol; 2003; 528():545-9. PubMed ID: 12918761
    [No Abstract]   [Full Text] [Related]  

  • 20. Infliximab treatment in psoriatic arthritis: our experience.
    Rioda WT; Adorni G
    Acta Biomed; 2006 Aug; 77(2):95-102. PubMed ID: 17172189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.